Top 20 of Pancreatic Neoplasms

Article title # Publications/# Citations

Analyzing real-time PCR data by the comparative C(T) method.

2008: KJLivak; TDSchmittgen;

1660

ras oncogenes in human cancer: a review.

1989: JLBos;

741

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.

2008: PAngenendt; ESCalhoun; HCarter; JREshleman; BFu; MGoggins; JHartigan; MHidalgo; ... SMHong; RHHruban; CIacobuzio-Donahue; EMJaffee; AJimeno; SJones; HKamiyama; MKamiyama; RKarchin; SEKern; KWKinzler; APKlein; SDLeach; RJLeary; JCLin; MTLin; AMaitra; PMankoo; TNikolskaya; YNikolsky; NPapadopoulos; GParmigiani; DWParsons; DRSmith; VEVelculescu; BVogelstein; KWalter; XZhang;

729

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

1997: JAndersen; HABurris; MCCripps; FADörr; MRGreen; MRModiano; MJMoore; RNelson; ... RKPortenoy; MLRothenberg; CDStephens; AMStorniolo; PTarassoff; DDVon Hoff;

531

Identification of pancreatic cancer stem cells.

2007: VAdsay; CFBurant; MFClarke; PDalerba; DGHeidt; CLi; DMSimeone; MWicha; LZhang;

499

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.

2007: National Cancer Institute of Canada Clinical Trials Group; HJAu; DCampos; GClark; KDing; AFiger; SGallinger; DGoldstein; ... JHamm; JRHecht; RLim; MJMoore; PMurawa; WParulekar; MPtasynski; TVoskoglou-Nomikos; DWalde; RAWolff;

464

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.

2007: DEArking; MABeer; TCChang; GFeldmann; MFerlito; OAKent; KHLee; CJLowenstein; ... AMaitra; JTMendell; MMullendore; KRamachandran; EAWentzel; MYamakuchi;

450

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.

2009: JAdams; DAllard; MECaldwell; AChang; CCombs; CJDavidson; SEDavies; GDeNicola; ... MDhara; MEgorin; CFeig; KKFrese; MAGoldgraben; AGopinathan; JGriffiths; RGrützmann; SRHingorani; DHoness; WJHowat; RHHruban; PHuang; CIacobuzio-Donahue; HIreland-Zecchini; KIzeradjene; MAJacobetz; BMadhu; KMcGovern; DMcIntyre; KPOlive; CPilarsky; WPlunkett; SReichelt; FRuckert; DATuveson; LWang; NWhitebread; SPWinter;

414

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis.

2000: GBergers; RBrekken; DHanahan; TItoh; SItohara; GMcMahon; KTamaki; KTanzawa; ... PThorpe; THVu; ZWerb;

401

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.

2007: AAicher; CJBruns; JWEllwart; MGuba; CHeeschen; PCHermann; THerrler; SLHuber;

375

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.

2003: TPConrads; HCCrawford; SRHingorani; BAHitt; RHHruban; TJacks; MAJacobetz; DJohann; ... YKawaguchi; CKing; LALiotta; AMLowy; AMaitra; EFPetricoin; MEPutt; VRajapakse; SRoss; DATuveson; TDVeenstra; CVWright;

369

Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

2012: SAgrawal; SAlaparthy; SBhatia; JRBrahmer; LHCamacho; SChen; LQChow; CGDrake; ... KEaton; SMGoldberg; JFGrosso; AGupta; OHamid; PHwu; WJHwu; JKauh; AJKorman; RMartins; KOdunsi; DMPardoll; SMParker; HCPitot; TMSalay; SLTopalian; SSTykodi; JMWigginton;

358

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1.

1996: LTda Costa; AFischer; SAHahn; ATHoque; RHHruban; SEKern; CAMoskaluk; ERozenblum; ... MSchütte; CLWeinstein; CJYeo;

326

Distant metastasis occurs late during the genetic evolution of pancreatic cancer.

2010: TAntal; IBozic; JREshleman; BFu; RHHruban; CAIacobuzio-Donahue; SJones; MKamiyama; ... KWKinzler; RLeary; MANowak; VEVelculescu; BVogelstein; SYachida;

290

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

2011: Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup; AAdenis; EAssenat; JBBachet; YBecouarn; JBennouna; OBouché; ... BChauffert; TConroy; Cde la Fouchardiere; CDelbaldo; FDesseigne; MDucreux; SGourgou-Bourgade; RGuimbaud; FKhemissa-Akouz; PMichel; CMontoto-Grillot; DPere-Verge; JLRaoul; MYchou;

290

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes.

1988: CAlmoguera; NArnheim; KForrester; JMartin; MPerucho; DShibata;

285

Pancreatic cancer.

2010: MHidalgo;

266

Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis.

2003: BAntoniu; MPdi Magliano; CFernández-del Castillo; SGysin; MHebrok; PWHeiser; GYLauwers; MMcMahon; ... CMNielsen; YPQi; DJRoberts; SPThayer; ALWarshaw; VYajnik;

257

Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes.

1985 May 9-15: DHanahan;

254

A causal role for E-cadherin in the transition from adenoma to carcinoma.

1998: GChristofori; UDahl; AKPerl; HSemb; PWilgenbus;

251